Wei Qin

10PUBLICATIONS
10CO-AUTHORS
Gene and molecular therapyNeural engineeringImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 10, 2025
Telitacicept versus mycophenolate mofetil in IgA nephropathy: a real-world comparative study of efficacy, renal outcomes and safety.

Yangyang He, Shasha Chen, Kaixiang Liu

|Mar 10, 2025
Risk Stratification in Immunoglobulin A Nephropathy Using Network Biomarkers: Development and Validation Study.

Jiaxing Tan, Rongxin Yang, Liyin Xiao

|Jul 29, 2024
The clinical and pathological evaluation of patients with immunoglobulin A nephropathy by diffusion tensor imaging and intravoxel incoherent motion diffusion-weighted imaging.

Huan Zhou, Yi Si, Ling Yang

|Jul 26, 2024
High systemic inflammatory response index (SIRI) is an independent risk factor for poor outcome in IgA nephropathy patients.

Dandan Yang, Huan Zhou, Wei Qin

|Oct 05, 2023
TRPA1 promotes cisplatin-induced acute kidney injury via regulating the endoplasmic reticulum stress-mitochondrial damage.

Fei Deng, Heping Zhang, Wei Zhou

|Sep 09, 2022
Triglyceride-Glucose Index May Predict Renal Survival in Patients with IgA Nephropathy.

Aiya Qin, Jiaxing Tan, Siqing Wang

Pageof 2

Frequent Collaborators

1 joint publications

Huan Zhou

1 joint publications

Xiaoyuan Zhou

1 joint publications

Jiaxing Tan

1 joint publications

Rongxin Yang